Big Pharma-Big Agra Mergers: Furthering the Synthetic Agenda
Big Pharma-Big Agra mergers have accelerated recently, with Syngenta
being bought by ChemChina (China National Chemical Corporation), Dow
Chemical merging with DuPont, and Monsanto agreeing to be acquired by
Bayer on Sept. 14th 2016 for US$66 billion. Bayer and Monsanto have
signed off on the deal. Syngenta had previously rejected a $47 billion
takeover bid by Monsanto last year in 2015. Now US and EU regulators
will examine the Bayer-Monsanto deal. If the deal is approved, this
new corporate behemoth would be the largest agribusiness on Earth,
selling 29% of the world’s seeds and 24% of the world’s pesticides. This
would constitute a massive consolidation of power into the hands of a
few, a power which would determine who gets seeds to grow food to eat,
and who doesn’t. Big Pharma and Big Biotech are in the same kind of
industries – using synthetic, artificial and chemical techniques to
“hack” life and duplicate products which are of inferior quality to the
original – and more harmful. Big Pharma-Big Agra mergers are therefore
to be expected, although that doesn’t make them any less dangerous. The
centralization of chemical production is indicative of the greater New
World Order plan of centralization of power – as well as the synthetic
agenda which underlines all its machinations.
